The role of combination therapy in managing pulmonary arterial hypertension
Why the study?
Does combination therapy improve outcomes in patients with pulmonary arterial hypertension?
Population
Patients with pulmonary arterial hypertension (PAH)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports sequential combination therapy in PAH; leaves open optimal regimens and need for confirmatory RCTs.
Structured PICO
Does combination therapy improve outcomes in patients with pulmonary arterial hypertension?
P
Population
Patients with pulmonary arterial hypertension (PAH)
I
Intervention
Combination therapy (sequential or upfront) targeting multiple pathways (endothelin, nitric oxide, prostacyclin)
This review highlights that recent long-term trial data support the clinical benefit of sequential combination therapy in managing pulmonary arterial hypertension.
Limitations
- Short-term trials have shown inconsistent results
- Short-term trials have not been powered to assess morbidity/mortality outcomes
Cite This Study
Marc Humbert (2014) studied this question.